Tag: THCZ

Blue Horseshoe Stocks: ADTM, THCZ & More

Adaptive Medias, Inc. ADTM

We highlighted ADTM several weeks ago on January 28th, and on that day we witnessed a low of 1.58. Over the course of the following month, the stock would gradually make its way to a high of 3.10 (March 4th). That was quite a substantial run, topping out at an increase of 96%

It took another eight sessions for ADTM to come down off of those highs and find support, which it did at 2.00 last Thursday. Since then it has been registering higher lows, and yesterday reached back to a PPS high of 2.41 (+20%), so we’re going to re-radar the stock and keep watch over it into next week.

Totally Hemp Crazy, Inc. THCZ

Another high-performance stock that we first came across a few months back was THCZ. We found this gem back on December 18th and it made a 38% gain for us that day as it ran from .013-.018, but the fun certainly wasn’t over.

It took about six weeks of essentially trading sideways before THCZ would begin one of the most epic runs we’ve seen from a cannabis related play since the ‘Green Rush’ of early 2014. It culminated in a new high during Wednesday’s session, with shares changing hands for as much as .14. That represents a massive spike from the lows we observed in late December totaling 977%

At this point, we’ll be watching to see where THCZ finds support again, where we’ll be waiting for the possibility of a bounce-play on the subsequent rebound. The company put out a fresh PR this morning as well.

Totally Hemp Crazy Inc. Orders Second Production Run in April of Rocky Mountain High Hemp Infused Beverages (Fri 8:00AM EDT)

Amarantus Bioscience Holdings, Inc. AMBS

We also want to make note of AMBS as the week draws to a close. We have an extensive history with this play, and we re-flagged it on Monday morning as a “Bottom-Watch” play. The ultimate low would come across the tape at the beginning of yesterday’s session at .05 before AMBS began to bounce back.

It reached its way back to .0595 (+18%) and closed there. Moving forward, we’re going to be looking for AMBS to register higher highs and higher lows off of its bottom. The stock was trading as high as .086 at the beginning of this month, and a return to that area from current levels would spell gains on the order of 40%
____

SIDE NOTE: Speaking of stocks on bottom-watch, we want to call attention to Ohr Pharmaceuticals, Inc. OHRP. The company announced this morning that it had failed to meet its goals in a Phase II study of its OHR-102 drug, and got absolutely crushed in premarket trading down to a low of 2.68. It has recovered slightly, and we’re going to have an eye on OHRP as the session kicks off. The rebound off of such a downturn could be significant.

Extended Watchlist:
RHT, BBRY, OREX, LIVE, VJET

Blue Horseshoe Stocks: APP, JNUG Reviews & More

American Apparel Inc. APP

When we began pounding the table on APP on Wednesday this week, it was for good reason. On that day we observed a low of .63. The chart was sending out bullish signals left, right, and center, and yesterday proved to be quite a day as the stock made a 58% intraday move from .72-1.14. That high also marked an overall increase of 81% over the low we witnessed the session prior.

APP is maintaining a majority of those gains, trading above a dollar in the premarket today so we’ve been provided with plenty of opportunity to take profits as the stock is on its way up. It remains to be seen if new CEO Paula Schneider can right the ship over time, but for now APP has given us the chance at some excellent short term gains.

Per the chart, 1.20 and 1.30 appear to be the next key areas of resistance. In order for us to remain interested in APP moving forward, we’ll need to see it maintain support at or above the .85-1.00 range.

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve tracked JNUG regularly this fall, and after tagging it in both Tuesday’s and yesterday’s extended watchlist, this ETF has gained a sizable bit of ground. Tuesday’s low was set at 1.82, meaning that as of yesterday’s high at 2.78, we saw a 53% increase out of JNUG over just a three-session span. That low also marked the 52-week low, so our timing here really couldn’t have been any better.

We also want to note that per a recent PR, Direxion will be enacting a 1-for-10 reverse split of the shares of JNUG on Dec. 23rd (This Tuesday).

Other Notable Movers From Yesterday’s Report

Yesterday’s newsletter also yielded an additional three chances to reap intraday profits:

Totally Hemp Crazy Inc. THCZ  –  Range: .013-.018  –  Gain: 38%

Agenus Inc. AGEN  –  Range: 3.59-3.96  –  Gain: 10%

Real Goods Solar, Inc. RGSE  –  Range: .63-.70  –  Gain: 11%

Extended Watchlist:
CERS, MOLG, FMD, TRXC, SVM, ORE

Blue Horseshoe Stocks: APP, CERS Recaps & More

American Apparel Inc. APP

It appears as if we brought APP back into the discussion yesterday at an opportune time, as the stock enjoyed a healthy intraday move on more than twice the 3-month average trading volume.

After briefly seeing a low of .63 the stock gradually built its way up to an afternoon high of .69, an increase of roughly 10%, and in the premarket this morning APP has already traded as high as .78. That pushes the overnight increase on APP to 24%

Yesterday we mentioned that breaking of the 200DMA of .74 was a key event that needed to take place and we’ve seen that happen this morning, so APP is certainly going to remain high on our watchlists as we head into week’s end.

Cerus Corp. CERS

CERS was included in yesterday’s extended watchlist, and made a solid move during the day’s session. From a low of 5.26 the stock made a run at a high of 5.94, a modest yet notable 13% increase.

It came on the heels of the announcement that the company had received the green light from the FDA on its product that limits the risk of infection-transmission in blood transfusions. We always like a good FDA-approval play so we will definitely be monitoring this play in coming sessions.

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection (TTI) when treating patients requiring therapeutic plasma transfusion. >> FULL PR

Eco Science Solutions, Inc. ESSI

We’ve still got ESSI on our radars, and wanted to remind our readers of this even as the stock has been trading in a tight channel between .20-.25 since we last took a look at it. The reason we still find ESSI attractive is that it boasts a tight share structure, and while we haven’t seen much in the way of volume, should that change, even the slightest amount of buying pressure could send ESSI flying.

From a business perspective, we’re also interested in the technology the company is working on, its innovative re-imagining on classic spark plug design. So despite not seeing much short-term activity, ESSI still has many of the hallmarks of a high-potential play that we’ll want to watch closely into the New Year.

We’ve drawn up a video on the current standing of the ESSI Chart, so take a look at that by clicking the graphic below:

If you missed our initial report on ESSI and its spark plug technology, go ahead and take a look now: ESSI Report

Extended Watchlist:
RAD, JNUG, EXXI, FRO, RGSE, AGEN, NQ, THCZ